Your browser doesn't support javascript.
loading
Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease.
Miller, Andrew T; Dahlberg, Carol; Sandberg, Mark L; Wen, Ben G; Beisner, Daniel R; Hoerter, John A H; Parker, Albert; Schmedt, Christian; Stinson, Monique; Avis, Jacqueline; Cienfuegos, Cynthia; McPate, Mark; Tranter, Pamela; Gosling, Martin; Groot-Kormelink, Paul J; Dawson, Janet; Pan, Shifeng; Tian, Shin-Shay; Seidel, H Martin; Cooke, Michael P.
Afiliação
  • Miller AT; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Dahlberg C; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Sandberg ML; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Wen BG; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Beisner DR; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Hoerter JA; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Parker A; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Schmedt C; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Stinson M; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Avis J; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Cienfuegos C; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • McPate M; Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom.
  • Tranter P; Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom.
  • Gosling M; Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom.
  • Groot-Kormelink PJ; Novartis Institutes for Biomedical Research, Musculoskeletal Disease Area, Basel, Switzerland.
  • Dawson J; Novartis Pharma AG, Novartis Institutes for Biomed. Research, Basel, Switzerland.
  • Pan S; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Tian SS; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Seidel HM; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
  • Cooke MP; The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America.
PLoS One ; 10(6): e0131071, 2015.
Article em En | MEDLINE | ID: mdl-26121493
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Linfócitos T CD4-Positivos / Fosfotransferases (Aceptor do Grupo Álcool) / Sinalização do Cálcio Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Linfócitos T CD4-Positivos / Fosfotransferases (Aceptor do Grupo Álcool) / Sinalização do Cálcio Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos